Aggregated proteins can trigger immune responses when injected
Besides diabetes and obesity management, GLP-1 drugs have shown many other potential benefits including: Lowering blood pressure Improving lipid disorders Improving fatty liver disease Reducing cardiovascular risk Decreases inflammation Reducing risk of kidney disease It is common for patients starting GLP-1 therapy to experience side effects during the first few weeks, including nausea, vomiting, headache, dizziness, and diarrhea
Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case control study
Activation of the MC1R and MC4R receptors can lead to anti-inflammatory actions, possibly lowering harmful immune responses
As a gastroenterologist, what's compelling here is the mechanism and the simplicity
Investigative Resources: A solid case is built on evidence